Literature DB >> 16009488

SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.

Ji Kon Ryu1, Woo Jin Lee, Kwang Hyuck Lee, Jin-Hyeok Hwang, Yong-Tae Kim, Yong Bum Yoon, Chung Yong Kim.   

Abstract

A novel hybrid synthetic histone deacetylase inhibitor, SK-7041, was synthesized from hydroaxamic acid of trichostatin A (TSA) and pyridyl ring of MS-275. TSA and SK-7041 both induced apoptosis and G2-M cell cycle arrest in pancreatic cancer cell lines. The expressions of p21 and cyclin D2 were up-regulated and that of cyclin B1 was down-regulated by TSA or SK-7041. The expression levels of Mcl-1 and Bcl-XL but not those of Bcl-2, Bax, and Bak were suppressed by TSA or SK-7041 treatment. SK-7041 or TSA induced apoptosis and G2-M cell cycle arrest by up-regulating p21 and down-regulating cyclin B1, Mcl-1, and Bcl-XL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009488     DOI: 10.1016/j.canlet.2005.05.040

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 2.  Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.

Authors:  Sau Wai Hung; Hardik R Mody; Rajgopal Govindarajan
Journal:  Cancer Lett       Date:  2012-03-13       Impact factor: 8.679

3.  Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.

Authors:  Theresa D Ahrens; Sylvia Timme; Jens Hoeppner; Jenny Ostendorp; Sina Hembach; Marie Follo; Ulrich T Hopt; Martin Werner; Hauke Busch; Melanie Boerries; Silke Lassmann
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  The molecular targets for the diagnosis and treatment of pancreatic cancer.

Authors:  Alexios S Strimpakos; Kostas N Syrigos; Muhammad Wasif Saif
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

5.  Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.

Authors:  Weiqiang Zhou; I-Chau Liang; Nelson S Yee
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

6.  HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.

Authors:  Dhanusha A Nalawansha; Inosha D Gomes; Magdalene K Wambua; Mary Kay H Pflum
Journal:  Cell Chem Biol       Date:  2017-04-06       Impact factor: 8.116

7.  Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.

Authors:  Li-Ning Xu; Xin Wang; Sheng-Quan Zou
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

8.  Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

Authors:  Viola Baradari; Michael Höpfner; Alexander Huether; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

9.  Lead Induces Apoptosis and Histone Hyperacetylation in Rat Cardiovascular Tissues.

Authors:  Li-Hui Xu; Fang-Fang Mu; Jian-Hong Zhao; Qiang He; Cui-Li Cao; Hui Yang; Qi Liu; Xue-Hui Liu; Su-Ju Sun
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 10.  Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Petra Fritsche; Susanne Schüler; Roland M Schmid; Dieter Saur
Journal:  J Cell Mol Med       Date:  2009-11-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.